Valvular Heart Disease: Clinical Trials

9 trials for Valvular Heart Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed. 9 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 49Completed 9

Follow Valvular Heart Disease: new trials by email Literature Review of Valvular Heart Disease trials Research Report on Valvular Heart Disease

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Topical Effect of Tranexamic Acid in Postoperative Bleeding and Blood Products Transfusion After Cardiac Surgery
Tranexamic Acid 100 MG/ML, normal saline - Coronary Artery Disease, Valvular Heart Disease
Phase 4CompletedUniversitas Indonesia1322022-10-012023-02-01
Sugammadex Titration in Cardiac Surgery Patients
Sugammadex administration - Coronary Artery Disease, Valvular Heart Disease
Phase 4CompletedUniversity of Washington1002022-02-012024-03-21
Hypertonic Saline for Fluid Resuscitation After Cardiac Surgery
Hypertonic saline, 0.9% saline - Cardiovascular Diseases, Valvular Heart Disease
Phase 4CompletedInsel Gruppe AG, University Hospital Bern1652018-02-272020-03-24
Effect of Anesthetics on CD39 and CD73 After Open-heart Surgery
Propofol, Sevoflurane - Valvular Heart Disease, Aortic Disease
Phase 4CompletedKonkuk University Medical Center22014-05-212018-01-18
Propofol Effects on Mitral Valve Annular Velocity
Propofol 1.0mcg, Propofol 2.0mcg, Propofol 3.0mcg - Valvular Heart Disease, Coronary Artery Disease
Phase 4CompletedKonkuk University Medical Center402013-04-012016-04-20
The Cortisol Levels During Cardiac Surgery. The Comparison Between Etomidate and Thiopentone
etomidate, thiopentone - Coronary Artery Disease, Valvular Heart Disease
Phase 4CompletedMahidol University922011-12-012014-05-23
Randomized Isoflurane and Sevoflurane Comparison in Cardiac Surgery
Volatile anesthetic - Coronary Artery Disease, Valvular Heart Disease
Phase 4CompletedLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's4642011-11-012015-06-08
Sildenafil for Secondary Pulmonary Hypertension Due to Valvular Disease
Sildenafil Citrate, Placebo - Pulmonary Hypertension, Valvular Heart Disease
Phase 4CompletedHospital General Universitario Gregorio Marañon2002009-04-012016-09-23
Humanalbumin, Hydroxyethylstarch and Ringer Lactate During Cardiac Surgery
volume replacement, Humanalbumin 5% - Valvular Heart Disease, Coronary Artery Disease
Phase 4CompletedMedical University of Vienna2402006-03-012015-04-08

Narrower conditions

Heart Valve Diseases (9)  ·  Coronary Artery Disease (6)  ·  Aortic Diseases (2)  ·  Blood Loss, Surgical (1)  ·  Cardiovascular Diseases (1)  ·  Heart Failure (1)  ·  Hypertension, Pulmonary (1)  ·  Postoperative Hemorrhage (1)

Broader conditions

Heart Diseases (9)  ·  Cardiovascular Diseases (8)  ·  Vascular Diseases (8)  ·  Arterial Occlusive Diseases (6)  ·  Arteriosclerosis (6)  ·  Coronary Disease (6)  ·  Myocardial Ischemia (6)  ·  Hemorrhage (1)  ·  Hypertension (1)  ·  Intraoperative Complications (1)  ·  Lung Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Postoperative Complications (1)  ·  Respiratory Tract Diseases (1)

Interventions

Propofol (2)  ·  Saline Solution (2)  ·  Etomidate (1)  ·  HES 130-0.4 (1)  ·  Hydroxyethyl Starch Derivatives (1)  ·  Saline Solution, Hypertonic (1)  ·  Sevoflurane (1)  ·  Sildenafil Citrate (1)  ·  Thiopental (1)  ·  Tranexamic Acid (1)

Sponsors

Konkuk University Medical Center (2)  ·  Hospital General Universitario Gregorio Marañon (1)  ·  Insel Gruppe AG, University Hospital Bern (1)  ·  London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (1)  ·  Mahidol University (1)  ·  Medical University of Vienna (1)  ·  Universitas Indonesia (1)  ·  University of Washington (1)

Countries

South Korea (2)  ·  Austria (1)  ·  Canada (1)  ·  Indonesia (1)  ·  Spain (1)  ·  Switzerland (1)  ·  Thailand (1)  ·  United States (1)

Top investigators

Eva M Base, MD (1)  ·  Javier Bermejo, MD, PhD (1)  ·  Joerg C Schefold, MD (1)  ·  Manee Raksakietisak, MD (1)  ·  Philip M Jones, MD MSc (1)  ·  Seong-Hyop Kim, M.D, Ph.D (1)  ·  T. Andrew Bowdle, MD, PhD (1)  ·  Tae-yop Kim, MD, PhD (1)

Results publications

PMID 16438759, PMID 17218108, PMID 26437535, PMID 27465213, PMID 29281101, PMID 30908754, PMID 31020819, PMID 31200756, PMID 33399006